{"id":7576,"date":"2024-07-18T16:01:28","date_gmt":"2024-07-18T15:01:28","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7576"},"modified":"2024-07-18T16:01:28","modified_gmt":"2024-07-18T15:01:28","slug":"anvisa-announces-new-procedure-medicines","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/","title":{"rendered":"Anvisa publishes a new procedure for medicines"},"content":{"rendered":"<\/p>\n<p style=\"text-align: center;\"><strong>Anvisa publishes a new procedure for medicines<\/strong><\/p>\n<p style=\"text-align: center;\">Brazil&#8217;s Anvisa (National Health Surveillance Agency) has published a new standard operating procedure for Medicines, according to RDC 823\/2023. The measure aims to reduce requirements for companies by 30%, focusing on quality in the registration and post-registration changes of synthetic and semi-synthetic medicines. <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2024\/anvisa-publica-procedimento-operacional-padrao-para-area-de-medicamentos\" target=\"_blank\" rel=\"noopener\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Read more here<\/span><\/a><\/p>\n<p style=\"text-align: center;\">If you need more information about the regularization of your medicines, ELS can certainly help.<\/p>\n<p style=\"text-align: center;\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Please do not hesitate to c<\/span>ontact your <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\" target=\"_blank\" rel=\"noopener\">local ELS consultant<\/a>\u00a0or via email info@elssolutions.pt<\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.<\/p>\n","protected":false},"author":9,"featured_media":7570,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-7576","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anvisa announces a new procedure for medicines<\/title>\n<meta name=\"description\" content=\"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa announces a new procedure for medicines\" \/>\n<meta property=\"og:description\" content=\"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-18T15:01:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Anvisa publishes a new procedure for medicines\",\"datePublished\":\"2024-07-18T15:01:28+00:00\",\"dateModified\":\"2024-07-18T15:01:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\"},\"wordCount\":812,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\",\"url\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\",\"name\":\"Anvisa announces a new procedure for medicines\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg\",\"datePublished\":\"2024-07-18T15:01:28+00:00\",\"dateModified\":\"2024-07-18T15:01:28+00:00\",\"description\":\"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Medicamentos que fazem parte do novo procedimento da Anvisa\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa publishes a new procedure for medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa announces a new procedure for medicines","description":"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Anvisa announces a new procedure for medicines","og_description":"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.","og_url":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-07-18T15:01:28+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Anvisa publishes a new procedure for medicines","datePublished":"2024-07-18T15:01:28+00:00","dateModified":"2024-07-18T15:01:28+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/"},"wordCount":812,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/","url":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/","name":"Anvisa announces a new procedure for medicines","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg","datePublished":"2024-07-18T15:01:28+00:00","dateModified":"2024-07-18T15:01:28+00:00","description":"Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg","width":1200,"height":600,"caption":"Medicamentos que fazem parte do novo procedimento da Anvisa"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/anvisa-announces-new-procedure-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anvisa publishes a new procedure for medicines"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=7576"}],"version-history":[{"count":2,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7576\/revisions"}],"predecessor-version":[{"id":7586,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7576\/revisions\/7586"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/7570"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=7576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=7576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=7576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}